L7 Informatics Raises $13M in Series B Financing

L7 Informatics Raises $13M in Series B Financing

AUSTIN, Texas, March 8, 2021 /PRNewswire/ — L7 Informatics, a leader in enterprise-scale digital transformation and automation of scientific processes in the life sciences and healthcare domains, announced that it closed its Series B financing round. The...
ReForm taps ex-Genzyme exec to lead subcutaneous delivery strategy

ReForm taps ex-Genzyme exec to lead subcutaneous delivery strategy

Jim Sherblom has joined ReForm Biologics as chair to lead a new strategy. The ex-Genzyme executive arrives at ReForm as it switches focus to the development of subcutaneous versions of intravenous products. In recent years, ReForm has worked on proprietary excipients...
Lucira Health launches $153M IPO

Lucira Health launches $153M IPO

Infectious diseases diagnostics company Lucira Health Inc. launched an IPO of 9 million shares of common stock at $17 per share, for expected gross proceeds of $153 million. Friday’s Wall Street debut was a show of confidence, upsized from an original plan to offer...